Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:57:10.002Z.
Calculation as of: 2026-10-06T16:57:10.002Z.
Quote observation: 2026-10-06T16:55:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 84f755396c9cc6b6c9535f897ba0f48fef5a33e79b5fb4c136097311f2feddf3
PEG RATIO
N/A
IM Cannabis Corp.
Market Cap
$1.15M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| IM Cannabis Corp. (IMCC) | $1.15M | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.14M | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.25M | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.32M | N/A |
| Genprex, Inc. (GNPX)vs › | $1.34M | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $881948.00 | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
